Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)

Overview of attention for article published in British Medical Journal, July 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 14 news outlets
blogs: 2 blogs
twitter: 107 X users

facebook: 4 Facebook pages
guideline: 3 clinical guideline sources

Readers on

mendeley: 516 Mendeley

So far, Altmetric has seen 127 X posts from 107 X users, with an upper bound of 981,153 followers.

@LesleyLesleys This echoes the work by @roma_maguire in the Real-time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/bWoPwFeAey #leadership

Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) @adarleyresearch https://t.co/OGqqFdPKZf #UCD #Research https://t.co/MmKkGjUvDp

Real time remote symptom monitoring during chemotherapy for cancer >> Significant reduction in symptom burden in European multicentre randomised controlled trial (eSMART) https://t.co/dvxW5ypKko

Monitoreo remoto y en tiempo real de los efectos secundarios durante la quimioterapia contra el cáncer, lo que sabemos: https://t.co/gaP42Qw6Yp https://t.co/d6NB13hbXp

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 123 additional X posts.